(VIANEWS) – The NASDAQ ended the session with Xenetic Biosciences (XBIO) rising 4.48% to $0.92 on Friday while NASDAQ rose 2.09% to $13,047.19.


Today’s last reported volume for Xenetic Biosciences is 16907, 67.28% below its average volume of 51679.

Xenetic Biosciences’s last close was $0.88, 84.51% under its 52-week high of $5.68.

Xenetic Biosciences’s Sales

Xenetic Biosciences’s sales growth is 72.4% for the current quarter and a decline by 33.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 90% and 6.3%, respectively.

Xenetic Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 154.7%, now sitting on 746.09k for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Xenetic Biosciences’s stock is considered to be overbought (>=80).

Xenetic Biosciences’s Stock Yearly Top and Bottom Value

Xenetic Biosciences’s stock is valued at $0.92 at 19:39 EST, way under its 52-week low of $1.21.

Xenetic Biosciences’s Moving Average

Xenetic Biosciences’s value is way below its 50-day moving average of $1.64 and way under its 200-day moving average of $2.19.

More news about Xenetic Biosciences (XBIO).


Please enter your comment!
Please enter your name here